Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...

Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...